Skip to main content Skip to main navigation menu Skip to site footer

The prevalence of long COVID symptoms in Indonesia: a cross-sectional study in Aceh

  • Maryatun Hasan ,
  • Wahyu Eka Sari ,
  • Agung Pranata ,

Abstract

Introduction: It is estimated that the long-term consequences of Coronavirus Disease 2019 (COVID-19) can be significant problems since they cause prolonged clinical manifestations after COVID-19. The aim of this study was to investigate patients with long-term effects of COVID-19 in Aceh Province, Indonesia.

Methods: A cross-sectional study was conducted on COVID-19 patients in Aceh, Indonesia using an online survey software tool. The COVID-19 survivors were contacted after a diagnosis of COVID-19 at least 14 days after a negative real time polymerase chain reaction (RT-PCR) result.

Results: A total of 303 respondents were contacted after a diagnosis of COVID-19 at least 14 days after a negative RT-PCR result. The results showed that 31% experienced long COVID until the 14th to 15th day of the month, while 69% did not offer long COVID symptoms. The most common symptoms experienced by the patients were fatigue (9.9%), headache (8.7%), and joint and muscle pain (8.1%). Other symptoms reported by COVID-19 survivors were polypnea and shortness of breath, sleep disturbances, coughing, hair loss, palpitations, runny nose, stuffy nose, mental health problems such as anxiety, impaired concentration and depression. The long COVID symptoms were more experienced by female respondents (64.9%) than male respondents (35.1%).

Conclusion: Our data suggested that the symptoms of long COVID or long-term consequences of COVID-19 were relatively high. Therefore, measures should be taken to prevent long-term effects among COVID-19 survivors.

References

  1. Kostov K V. Ongoing COVID-19 syndrome and post-COVID-19 syndrome: Long-term symptoms and residual changes after SARS-CoV-2 infection. Biomed Rev. 2020;31(0):117. Available from: http://dx.doi.org/10.14748/bmr.v31.7711
  2. Servick K. For survivors of severe COVID-19, beating the virus is just the beginning. Science (80- ). 2020; Available from: http://dx.doi.org/10.1126/science.abc1486
  3. Mahase E. Long covid could be four different syndromes, review suggests. BMJ. 2020;m3981. Available from: http://dx.doi.org/10.1136/bmj.m3981
  4. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The lancet Psychiatry. 2020/11/09. 2021;8(2):130–40. Available from: https://pubmed.ncbi.nlm.nih.gov/33181098
  5. Fahriani M, Ilmawan M, Fajar JK, Maliga HA, Frediansyah A, Masyeni S, et al. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - A systematic review and meta-analysis. Narra J. 2021;1(2). Available from: http://dx.doi.org/10.52225/narraj.v1i2.36
  6. Fajar JK, Ilmawan M, Mamada S, Mutiawati E, Husnah M, Yusuf H, et al. Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis. Narra J. 2021;1(3). Available from: http://dx.doi.org/10.52225/narra.v1i3.48
  7. Neumiller JJ, Lienhard FJ, Alicic RZ, Tuttle KR. Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors. TouchREVIEWS Endocrinol. 2022/11/29. 2022;18(2):106–15. Available from: https://pubmed.ncbi.nlm.nih.gov/36694888
  8. Razonable RR, Ganesh R, Bierle DM. Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19. Mayo Clin Proc. 2021/11/19. 2022;97(1):26–30. Available from: https://pubmed.ncbi.nlm.nih.gov/34996562
  9. Del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17):1723–4. Available from: https://pubmed.ncbi.nlm.nih.gov/33031513
  10. Soni SN, Nimbalkar SM. Long COVID Syndrome Following Infection with SARS-CoV-2- A Devastating Influence on Health Status in Some Affected Individuals. J Clin DIAGNOSTIC Res. 2021; Available from: http://dx.doi.org/10.7860/jcdr/2021/47609.14571
  11. Carfì A, Bernabei R, Landi F, Group GAC-19 P-ACS. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–5. Available from: https://pubmed.ncbi.nlm.nih.gov/32644129
  12. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–73. Available from: https://pubmed.ncbi.nlm.nih.gov/32730619
  13. Shi P, Dong Y, Yan H, Zhao C, Li X, Liu W, et al. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ. 2020/04/23. 2020;728:138890. Available from: https://pubmed.ncbi.nlm.nih.gov/32339844
  14. Al-Jahdhami I, Al-Naamani K, Al-Mawali A. The Post-acute COVID-19 Syndrome (Long COVID). Oman Med J. 2021;36(1):e220–e220. Available from: https://pubmed.ncbi.nlm.nih.gov/33537155
  15. Raveendran A V, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021/04/20. 2021;15(3):869–75. Available from: https://pubmed.ncbi.nlm.nih.gov/33892403

How to Cite

Hasan, M., Sari, W. E. ., & Pranata, A. . (2023). The prevalence of long COVID symptoms in Indonesia: a cross-sectional study in Aceh. Bali Medical Journal, 12(3), 3326–3330. https://doi.org/10.15562/bmj.v12i3.4756

HTML
3

Total
0

Share

Search Panel